Theme Center for Immune Modulatory Therapies for Autoimmunity and Cancer
The thematic center has been conceived with the vision of creating a "virtual institute" for developing innovative immune-based treatment approaches. Autoimmune and malignant diseases are the two primary foci for the development of therapeutic applications within this thematic center.
Specific immunological modalities that will be examined for therapeutic applications include antibodies, vaccines and adoptive transfer of immune cells (T cells, NK cells) modified ex vivo.
Basic research within the scope of the consortium will be primarily directed at elucidating new mechanisms and pathways and identifying molecules and structures that may be utilized for therapy. These basic discoveries will be translated to knowledge-based therapeutic approaches. A select number of these therapeutic entities will then be tested in investigator-initiated clinical trials for safety and efficacy.
Contact
Management
Director, Professor Rolf Kiessling
Department of Oncology-Pathology- Work:
- +46-(0)8-517 768 57
- E-mail:
- Address:
-
-
Visiting address:
Cancercenter Karolinska R8:01
Karolinska Universititetssjukhuset Solna
Postal address:
Karolinska Institutet
Department of Oncology-Pathology
SE-171 77 Stockholm
SWEDEN
-
Visiting address:
Co-Director, Adjunct professor Anders Österborg
Department of Oncology-Pathology- E-mail:
Group leaders
Associate professor Petter Höglund
Department of Microbiology, Tumour and Cell Biology- Work:
- +46-(0)8-524 862 01
- E-mail:
Professor Klas Kärre
Department of Microbiology, Tumour and Cell Biology- Work:
- +46-(0)8-524 862 82
- E-mail:
PhD MD Karl Johan Malmberg
Department of Medicine, Huddinge- Work:
- +46-(0)8-585 896 35
- E-mail:
Professor Håkan Mellstedt
Department of Oncology-Pathology- Work:
- +46-(0)8-517 743 08
- E-mail:
Professor Annika Scheynius
Department of Medicine, Solna- Work:
- +46-(0)8-517 759 34
- E-mail:
Professor Ola Weiland
Department of Medicine, Huddinge- Work:
- +46-(0)8-585 822 73
- E-mail:
